Monitoring Agency Report for the quarter ended 30 June 2025
HSCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Himadri Speciality Chemical has submitted the Monitoring Agency Report prepared by ICRA Limited for Q1 FY2026, covering the use of proceeds from its Preferential Issue of Convertible Warrants. The total issue size was ₹341.82 crore (1,08,17,000 warrants at ₹316 each), of which ₹89.25 crore was actually received as on 30 June 2025. Of the amount received, ₹82.87 crore was utilized during the quarter, entirely towards General Corporate Purposes (out of the ₹85 crore allocated for that purpose). No amount was spent on the Capital Expenditure object during the quarter, leaving ₹250.44 crore unutilized under that head. ICRA noted no deviation in the use of proceeds and confirmed that the spending is in line with the stated objects of the issue, with no major deviations flagged compared to earlier reports.
This is a routine SEBI compliance filing with a clean Monitoring Agency report — no red flags on fund use. For shareholders, it confirms proceeds are being deployed as promised, though capital expenditure deployment has been slow in Q1 FY2026.